Endocrine Abstracts

In this study, we enrolled 123 patients with DM2 that accordingly to the based on evidence clinical judgment, needed injectable treatment for the achievement of good glycaemic control. There was not significant changes at the whole sample in anthropometrics, but there was increase in insulin treated subgroup and decrease in GLP1 treated subgroup. Glycaemic control was improved (P<0.001), without differences between detemir vs glargine subgroups, but with more impr...